financetom
Business
financetom
/
Business
/
Denali-Sanofi scraps mid-stage study for multiple sclerosis drug
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Denali-Sanofi scraps mid-stage study for multiple sclerosis drug
Oct 10, 2024 6:09 PM

Oct 10 (Reuters) - Drug developer Denali Therapeutics ( DNLI )

said on Thursday its partner Sanofi has

discontinued a mid-stage study testing their experimental drug

to treat multiple sclerosis as it failed to meet the main and

secondary goals.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
EU court adviser sides with regulators in Google's fight against EU antitrust fine
EU court adviser sides with regulators in Google's fight against EU antitrust fine
Jun 19, 2025
BRUSSELS (Reuters) -An adviser to Europe's highest court on Thursday sided with EU antitrust regulators in Alphabet unit Google's fight against a record 4.3-billion-euro ($4.93 billion) fine levied on the U.S. tech giant by EU antitrust regulators seven years ago. Advocate General Kokott proposes that the Court of Justice dismiss Google's appeal and, therefore, that it confirm the new fine...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Britain awards floating offshore wind leases to Equinor and Gwynt Glas
Britain awards floating offshore wind leases to Equinor and Gwynt Glas
Jun 19, 2025
LONDON, June 19 (Reuters) - Equinor ( EQNR ) and Gwynt Glas have won seabed leases to build floating wind farms in the Celtic Sea off the coast of Wales and South West England, the Crown Estate said on Thursday. The Crown Estate, which acts as manager of the seabed around England, Wales and Northern Ireland, said Equinor ( EQNR...
EU court adviser sides with regulators in Google's fight against EU antitrust fine
EU court adviser sides with regulators in Google's fight against EU antitrust fine
Jun 19, 2025
BRUSSELS, June 19 (Reuters) - An adviser to Europe's highest court on Thursday sided with EU antitrust regulators in Alphabet unit Google's fight against a record 4.3-billion-euro ($4.93 billion) fine levied on the U.S. tech giant by EU antitrust regulators seven years ago. Advocate General Kokott proposes that the Court of Justice dismiss Google's appeal and, therefore, that it confirm...
Copyright 2023-2026 - www.financetom.com All Rights Reserved